Molecular Imaging signs pact with Signet Diagnostic Imaging Services Group

Molecular Imaging Corp. will provide positron emission tomography (PET) scanning services under a new multi-year agreement with Signet Diagnostic Imaging Services Group LLC.

Molecular Imaging will use a PET/CT unit to initially service six of Signet's medical imaging centers in Florida. Signet currently operates 16 multi-modality medical imaging centers in Florida and Puerto Rico.

"As patients and their doctors become more acquainted with PET/CT technology, and its potential for improving patient care, the demand for access to services will escalate," said Peter S. Conti, M.D., Ph.D., chairman of Molecular Imaging's medical advisory board.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.